{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-018565","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.200594+00:00","generated_at":"2026-06-08T06:31:29.631059+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nutex Health Q3 revenue $62.7M, up 121% YoY; Adj. EBITDA $1.3M; guides five new hospitals in 2024","bullets":["Net loss attributable to Nutex Health $(5.5)M; Q3 2022 loss $(412.2)M included $398M goodwill impairment.","Adjusted EBITDA of $1.3M; net cash from operating activities of $2.0M in Q3 2023.","Expects to open five new micro-hospitals in 2024; raised $4.4M from $15M private offering through Nov. 6, 2023.","Appointed Josh DeTillio as COO on Sept 5, 2023; acquired two Florida IPAs with 4,400 managed care patients.","Cash and cash equivalents of $26.8M as of Sept 30, 2023; total assets $479.6M."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-018565","json":"https://secwatch.observer/filing/0001558370-23-018565.json","markdown":"https://secwatch.observer/filing/0001558370-23-018565.md","text":"https://secwatch.observer/filing/0001558370-23-018565.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/0001558370-23-018565-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/nutx-20231109x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:31:29.631059+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63010f577b96a7d9d85a69d17f9972e92dcb8217","claim":"Nutex Health Inc. reported the three months and nine months ended September 30, 2023 results: revenue $62.7 million, net income Net loss attributable to Nutex Health of $(5.5) million in Q3 2023 and $(14.2) million for the first nine months of 2023.","evidence_excerpt":"is furnished as Exhibit 99.1 to this Current Report on Form 8-K. --- EX-99.1 (EX-99.1) --- NUTEX HEALTH reports THIRd quarter 2023 financial results ​ ● NET revenue of $62.7 million ● NET CASH FROM OPERATING ACTIVITIES OF $2.0 MILLION ● Company expects to open FIVE NEW MICRO-HOPITALS IN 2024 ​ HOUSTON, TX − (PRNewswire) – November 9, 2023 – Nutex Health Inc.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1479681/000155837023018565/0001558370-23-018565-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months and nine months ended September 30, 2023"},{"label":"Revenue","value":"$62.7 million"},{"label":"Net income","value":"Net loss attributable to Nutex Health of $(5.5) million in Q3 2023 and $(14.2) million for the first nine months of 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}